BioPharma Resources

Therapeutic area

Respiratory

Asthma, COPD, cystic fibrosis, pulmonary fibrosis and pulmonary hypertension. Drugs are placed in areas by keyword matches on their FDA pharmacologic class and approved use, and trials by their listed conditions, so a few land in the wrong area.

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.govMethods & limitations

Approvals since 2023

6

Originals, plus breakthrough or accelerated new uses

Recruiting Phase 2

82

Industry-sponsored

Recruiting Phase 3

63

Industry-sponsored

Recruiting Phase 4 (post-approval)

7

Industry-sponsored

Recent approvals

All
  • Exdensur (Depemokimab-Ulaa) · Glaxosmithkline LLC NovelDec 16, 2025

    To treat severe asthma characterized by an eosinophilic phenotype as an Komziftiadd-on maintenance therapy

  • Jascayd (Nerandomilast) · Boehringer Ingelheim NovelBreakthrough therapyPriority reviewOrphanOct 7, 2025

    To treat idiopathic pulmonary fibrosis

  • Brinsupri (Brensocatib) · Insmed INC NovelBreakthrough therapyPriority reviewAug 12, 2025

    To treat non-cystic fibrosis bronchiectasis

  • Alyftrek (Deutivacaftor, Tezacaftor, Vanzacaftor Calcium) · Vertex Pharms INC NovelPriority reviewOrphanDec 20, 2024

    For the treatment of cystic fibrosis (CF) in patients 6 years of age and older

  • Ohtuvayre (Ensifentrine) · Msd NovelJun 26, 2024

    To treat chronic obstructive pulmonary disease

  • Winrevair (Sotatercept-Csrk) · Merck Sharp Dohme NovelBreakthrough therapyPriority reviewOrphanMar 26, 2024

    To treat pulmonary arterial hypertension

Recruiting trials by phase

Industry-sponsored drug and biologic trials.

Most approvals since then, by company

Drugs in development

Investigational drugs in Phase 2 and 3 trials for conditions in this area, most trials first.

All
  • BrenipatideLY3537031Phase 313 trials

    Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major

  • PovorcitinibINCB054707, INCB54707Phase 312 trials

    Incyte · Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Prurigo Nodularis

  • CM512Phase 39 trials

    Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma

  • HSK44459Phase 39 trials

    Haisco Pharmaceutical Group Co., Ltd. · Psoriasis, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis

  • ItepekimabREGN3500, SAR440340Phase 39 trials

    Sanofi · Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps, Bronchiectasis

  • LP-003SinglePhase 39 trials

    Longbio Pharma · Allergic Asthma, Chronic Spontaneous Urticaria (CSU), Peanut Allergies

  • LunsekimigSAR443765Phase 39 trials

    Sanofi · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps

  • GSK5784283Phase 38 trials

    GSK · Pulmonary Disease, Chronic Obstructive, Asthma, Nasal Polyps

  • PF-07275315tilrekimigPhase 38 trials

    Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease

  • INS1009Treprostinil PalmitilPhase 37 trials

    Insmed Incorporated · Interstitial Lung Disease, Pulmonary Hypertension, Pulmonary Arterial Hypertension

  • MG-K10Humanized Monoclonal AntibodyPhase 36 trials

    Shanghai Mabgeek Biotech.Co.Ltd · Dermatitis, Atopic, Chronic Urticaria, Idiopathic, Atopic Dermatitis

  • SHR-1905Phase 36 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma, Chronic Rhinosinusitis With Nasal Polyps, Moderate-to-severe Atopic Dermatitis

  • TozorakimabMEDI3506Phase 36 trials

    AstraZeneca · Chronic Obstructive Pulmonary Disease (COPD), Asthma, Viral Lung Infection and Acute Respiratory Failure

  • CM310Phase 35 trials

    Keymed Biosciences Co.Ltd · Atopic Dermatitis, Moderate to Severe Asthma, Chronic Obstructive Pulmonary Disease

  • Inhaled TreprostinilLIQ861 Inhaled Treprostinil, Inhaled prostacyclinPhase 35 trials

    United Therapeutics · Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis

Largest recruiting Phase 3 trials

All

More: Respiratory news · literature

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.